Son[VEER]
Upgrade · Coming SoonNATCOPHARM
NSE: NATCOPHARM
₹925.05
Healthcare · Nifty 500 · as of 28JUL2026
Swing Read
↑ Veering Up · 0.61
Score
61/100
This is a percentile rank of this stock against the rest of the Nifty 500 today, not a probability or return forecast.
Swing Drivers
TechPrice Momentum
Adaptive trend slope over the last 50 sessions.
1005.5886
as of 28JUL2026
+1 pts to score
ContrarianVolume Pressure
Recent volume-backed move. Historically tends to partially reverse over the following weeks.
1.1071
as of 28JUL2026
+3 pts to score
ContrarianSector Momentum (Short-Term)
Stock's recent strength vs. its sector. Short-term outperformance has historically faded, not continued.
-0.0253
as of 28JUL2026
+2 pts to score
TechSector Momentum (Extended)
Stock's medium-term strength vs. its sector.
-0.2993
as of 28JUL2026
Not part of this score
ContrarianVolatility Regime
Current volatility vs. the stock's own recent range. Elevated readings have historically preceded softer forward returns.
0.0100
as of 28JUL2026
+5 pts to score
What changed, and when
28JUL2026
↑ Flipped to Veering Up
Driven by: Volume Pressure, Volatility Regime
24JUL2026
• Flipped to Neutral / No Clear Read
Driven by: Volatility Regime, Volume Pressure
20JUL2026
↓ Flipped to Veering Down
Driven by: Volatility Regime, Volume Pressure
17JUL2026
• Neutral / No Clear Read · first read on record
Sector Peers · Healthcare
Past Prints
Track record begins at launch. Check back soon.